Monocyte Subsets
Showing 1 - 25 of 650
Regional Anesthesia, General Anesthesia, Immune Function Trial in Homburg
Completed
- Regional Anesthesia
- +2 more
-
Homburg, Saarland, GermanySven O. Schneider, MD
May 10, 2022
sCD14 and sCD163 in Children With Type 1 Diabetes Mellitus
Not yet recruiting
- Type1diabetes
- ELISA
- (no location specified)
Apr 21, 2022
Immune System, Nutrition, Inflammation Trial in Davis (High saturated fat challenge meal, High mono unsaturated fat challenge
Not yet recruiting
- Immune System
- +2 more
- High saturated fat challenge meal
- High mono unsaturated fat challenge meal
-
Davis, CaliforniaUSDA Western Human Nutrition Research Center
Mar 29, 2023
Monocyte Phenotypic Changes in Heart Failure
Recruiting
- Heart Failure
- Decompensated Heart Failure
-
Ann Arbor, MichiganUniversity of Michigan Health System
Jan 27, 2022
Myocardial Fibrosis Associated With Monocyte Phenotype in End
Withdrawn
- Myocardial Fibrosis
- +4 more
- Cardiac MRI 1 - With Gadolinium Contrast
- +4 more
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 30, 2021
Plaque Psoriasis Trial in Cleveland (Apremilast)
Completed
- Plaque Psoriasis
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Nov 17, 2021
Influenza, Human Trial in Leiden (POLB 001, Placebo)
Completed
- Influenza, Human
- POLB 001
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Mar 13, 2023
Inflammatory Response, Diabetes type1, Hypoglycemia Trial in Nijmegen (Adrenaline)
Not yet recruiting
- Inflammatory Response
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud UMC
Aug 10, 2023
Healthy Volunteers Trial in Baltimore (EI1071, Matching Placebo)
Completed
- Healthy Volunteers
- EI-1071
- Placebo
-
Baltimore, MarylandParexel Early Phase Clinical Unit
Oct 20, 2022
Ketosis, Type 2 Diabetes Trial in Kelowna (Ketone monoester, Placebo)
Completed
- Ketosis
- Type 2 Diabetes
- Ketone monoester
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan
Jul 29, 2022
Endothelial Function and Regenerative Cell Exhaustion
Not yet recruiting
- Diabetes Mellitus, Type 2
-
Scarborough, Ontario, CanadaDiagnostic Assessment Centre
Oct 25, 2023
Sex Hormone and Vascular Function in Women With CKD
Recruiting
- Chronic Kidney Diseases
- No intervention
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Aug 11, 2022
Subclinical Cytomegalovirus Reactivation in Acute
Recruiting
- ANCA Associated Vasculitis
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham
Jan 15, 2023
Chronic Heart Failure Trial in Amsterdam (Endocalyx Pro, )
Recruiting
- Chronic Heart Failure
- Endocalyx Pro
- placebo
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Jul 21, 2023
Targeting Glutamine Metabolism to Prevent Diabetic
Recruiting
- Glutamine
- +2 more
- Bio collection
-
Paris, France
- +1 more
Jul 7, 2022
Systemic and White Adipose Tissue Inflammatory Profile in Lean
Completed
- Inflammation
- +3 more
- No intervention
-
Loughborough, United KingdomLoughborough University
May 15, 2022
Inflammation, Vaccine, Intestinal Permeability Trial in Davis (Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine)
Recruiting
- Inflammation
- +3 more
- Inulin
- +2 more
-
Davis, CaliforniaUSDA, ARS, Western Human Nutrition Research Center
Nov 29, 2022
Obesity Adult Onset Trial in Chapel Hill (SPM Active)
Completed
- Obesity Adult Onset
- SPM Active
-
Chapel Hill, North CarolinaUNC Chapel Hill Family Medicine Center
Jun 14, 2022
Exercise Physiology Trial in Houston (Resistance training exercise, Aerobic training exercise)
Suspended
- Exercise Physiology
- Resistance training exercise
- Aerobic training exercise
-
Houston, TexasUniversity of Houston
Feb 5, 2021
Autoreactive B Cells in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- In vitro assays.
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Nov 2, 2022
Sepsis Trial in United Kingdom (Prevenar 13, Sodium Chloride 0.9%)
Active, not recruiting
- Sepsis
- Prevenar 13
- Sodium Chloride 0.9%
-
Belfast, United Kingdom
- +11 more
Dec 12, 2022
Inflammasome-activating NLRP3 Gene in Monocytes From Atrial
Recruiting
- Atrial Fibrillation
- Arrhythmia
-
New Orleans, LouisianaTulane University Medical Center
Nov 3, 2021
Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)
Completed
- Atherosclerotic Vascular Disease
- +2 more
- Placebo
- Evolocumab
-
New York, New York
- +1 more
Jul 11, 2022
Vascular Access for Hemodialysis and Inflammation
Completed
- Vascular Access for Hemodialysis and Inflammation
-
Bologna, ItalyNephrology Dialysis Transplantation Unit St.Orsola University Ho
Mar 17, 2021